Search
for
Sort by
Research 181–210 of 774
- Application of Baricitinib in Dermatology
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- 54022 Pooled Safety Assessments from the Multinational Phase 3 THRIVE-AA1 and THRIVE-AA2 Trials of Deuruxolitinib in Adult Patients with Moderate to Severe Alopecia Areata
- 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study
- A Cost-per-Responder Analysis of Ritlecitinib vs Baricitinib in Severe Alopecia Areata
- Real‐World Efficacy and Safety of Tofacitinib for Patients With Alopecia Areata: A Retrospective Multi‐Center Cohort Study
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Revolutionary Approaches to Hair Regrowth: Follicle Neogenesis, Wnt/ß-Catenin Signaling, and Emerging Therapies
- Topical Ruxolitinib in Combination with Oral Minoxidil Results in Hair Regrowth in a Patient with Central Centrifugal Cicatricial Alopecia and Concomitant Traction Alopecia
- Efficacy and Safety of Switching from Baricitinib to Ritlecitinib in Severe Alopecia Areata
- 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata
- Topical tofacitinib for patients with lichen planopilaris and/or frontal fibrosing alopecia
- Concomitant management of alopecia universalis and ulcerative colitis with upadacitinib
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Treatment of concomitant alopecia areata and systemic lupus erythematosus with ivarmacitinib: a case report and literature review
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- Successful treatment with upadacitinib in concurrent atopic dermatitis, Crohn’s disease, alopecia areata, and eosinophilic gastropathy in a pediatric patient
- Upadacitinib for Alopecia: Current Evidence and Clinical Insights
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Modern dermatology brings treatment even for alopecia areata
- Upadacitinib Efficacy for the Treatment of Concomitant Psoriasis and Alopecia Areata
- Emerging role of baricitinib in dermatology practice: All we need to know!
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Baricitinib for the treatment of severe alopecia areata: results from a 52-week multicenter retrospective real-world study
- Successful hair regrowth in a Korean patient with alopecia universalis following tofacitinib treatment
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- A Case of Alopecia Totalis with Lichen Planus Hypertrophicus Responded Excellently to Oral Tofacitinib-An Observation
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Ruxolitinib: A novel molecule in the management of dermatological disorders